Suppr超能文献

固醇载体蛋白1的纯化及特性

Purification and properties of sterol carrier protein1.

作者信息

Srikantaiah M V, Hansbury E, Loughran E D, Scallen T J

出版信息

J Biol Chem. 1976 Sep 25;251(18):5496-504.

PMID:965373
Abstract

Previous studies have demonstrated that both the 105,000 X g soluble supernatant (S105) and microsomal membranes from rat liver are required for the enzymatic conversion of squalene to cholesterol (Scallen, T.J., Dean, W.J., and Schuster, M.W. (1968) J. Biol. Chem. 243, 5202). It was postulated that S105 contained a noncatalytic carrier protein which was required for this enzymatic process (Scallen, T. J., Schuster, M.W., and Dhar, A.K. (1971) J. Biol. Chem. 246, 224). Later evidence demonstrated that S105 contained at least two proteins which were required for the microsomal conversion of squalene to cholesterol (Scallen, T.J., Srikantaiah, M.V., Seetharam, B., Hansbury, E., and Gavey, K.L. (1974) Fed. Proc. 33, 1733). This article describes the purification and properties of the first of these soluble proteins, sterol carrier protein1 (SCP1), which has been purified 575-fold from rat liver S105. While SCP1 specifically activated the enzymatic conversion of squalene to lanosterol by liver microsomal membranes, SCP1 possessed no capacity to activate the microsomal conversion of [3H-A14,4-dimethyl-delta8-cholestenol to C27 sterols or of [3H]7-dehydrocholesterol to cholesterol. Lanosterol was identified by silicic acid chromatography and mass spectrometry. The formation of lanosterol was a hyperbolic function of the concentration of SCP1 present in the incubation mixture. The Km observed for SCP1 was similar to the Km observed for squalene. The formation of lanosterol from squalene required FAD. The addition of phosphatidylserine increased enzymatic activity; however, phosphatidylserine was not required for this conversion. SCP1 was catalytically inactive when it was incubated with [3H] squalene and cofactors in the absence of microsomes. Substantial evidence supports the hypothesis that SCP1 operates as a noncatalytic carrier protein for the water-insoluble substrate squalene in the enzymatic conversion of squalene to lanosterol by liver microsomal membranes.

摘要

先前的研究表明,大鼠肝脏的105,000 X g可溶性上清液(S105)和微粒体膜对于将角鲨烯酶促转化为胆固醇都是必需的(斯凯伦,T.J.,迪恩,W.J.,和舒斯特,M.W.(1968年)《生物化学杂志》243卷,5202页)。据推测,S105含有一种非催化性载体蛋白,该蛋白是此酶促过程所必需的(斯凯伦,T.J.,舒斯特,M.W.,和达尔,A.K.(1971年)《生物化学杂志》246卷,224页)。后来的证据表明,S105含有至少两种蛋白,它们是角鲨烯微粒体转化为胆固醇所必需的(斯凯伦,T.J.,斯里坎塔亚,M.V.,塞瑟拉姆,B.,汉斯伯里,E.,和加维,K.L.(1974年)《联邦会议录》33卷,1733页)。本文描述了这些可溶性蛋白中的第一种,即甾醇载体蛋白1(SCP1)的纯化及特性,它已从大鼠肝脏S105中纯化了575倍。虽然SCP1特异性地激活了肝脏微粒体膜将角鲨烯酶促转化为羊毛甾醇的过程,但SCP1没有能力激活微粒体将[3H-A14,4-二甲基-δ8-胆甾烯醇转化为C27甾醇或[3H]7-脱氢胆固醇转化为胆固醇的过程。羊毛甾醇通过硅酸色谱法和质谱法进行鉴定。羊毛甾醇的形成是孵育混合物中SCP1浓度的双曲线函数。观察到的SCP1的Km与观察到的角鲨烯的Km相似。从角鲨烯形成羊毛甾醇需要FAD。添加磷脂酰丝氨酸可提高酶活性;然而,此转化过程并不需要磷脂酰丝氨酸。当SCP1在无微粒体的情况下与[3H]角鲨烯和辅因子一起孵育时,它没有催化活性。大量证据支持这样的假说,即在肝脏微粒体膜将角鲨烯酶促转化为羊毛甾醇的过程中,SCP1作为水不溶性底物角鲨烯的非催化性载体蛋白发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验